Objective-A strategy was evaluated for identifying a proportion of children with long QT syndrome (LQTS) using the rate corrected QT interval (QTc) to systematically evaluate children who faint. Methods-QTc measurements and rates of fainting for the present analysis are available from families with KVLQT1, HERG, or SCN5A genotypes. QTc distributions in aVected and unaVected children were documented and detection and false positive rates were modelled. Results-The mean QTc (SD) in 117 aVected children was 0.484 seconds (0.031), and 0.420 seconds (0.021) among 133 unaVected children. At a cut oV of 0.49 seconds, QTc measurement will identify 42.5% of aVected and 0.1% of unaVected persons with a history of fainting who are alive at the time of testing. Assumptions include a prevalence of 1:5000 for LQTS, 2% mortality with the first arrhythmia, and a rate of fainting of 50% in aVected children and 7% in unaVected children. Given these variables, a QTc cut oV of 0.49 seconds detects 42 of 200 aVected, along with 70 unaVected children out of a population of 1 million. If QTc >0.49 seconds is found in either parent of children with a QTc of 0.44 through 0.48 seconds, another 21 aVected and 25 unaVected children will be identified.
Long QT syndrome (LQTS) can cause sudden, unexpected death in seemingly healthy children. 1 Treatment with a -blocker has been eVective in preventing death in most cases, once the condition is identified. [2] [3] [4] In a separate analysis, we have shown that there are multiple problems with population screening for this condition. 5 For this reason, we sought an alternative approach for detecting LQTS. About half of the people with LQTS will experience at least one fainting episode from which they recover. 6 7 Thus, the clinical evaluation after fainting in children might oVer an opportunity to detect the condition and introduce eVective treatment. In the preceding paper, 5 we have determined the detection rates and false positive rates at multiple rate corrected QT interval cut oV points in children and adolescents less than 16 years of age. In the present paper we make use of those calculations to evaluate a strategy for detecting LQTS, as part of the clinical investigation of children with a history of fainting.
Methods
In a separate analysis we modelled the detection rate (DR), false positive rate (FPR), and odds of being aVected given a positive test result (OAPR) for the rate corrected QT (QTc) interval, from 117 aVected children and their 133 unaVected siblings in 27 multigenerational families with LQTS. 5 This model is now applied to a subpopulation of children with a history of fainting, to assess how eVectively LQTS may be identified under these circumstances. We use patient interview data from published studies to determine the rate of fainting in aVected and unaVected children. 6 7 
Results
The modelled data from aVected and unaffected children are shown in table 1 with DR, FPR, and OAPR listed for each rate corrected QT interval cut oV point, at a population frequency of 1:5000 for LQTS. Table 2 stratifies the QTc measurements as a first step in assessing how they might be applied to children with fainting.
INITIAL ECG IN CHILDREN AFTER A FAINT
In figure 1 the prevalence of LQTS is assumed to be 1:5000 in a hypothetical group of 1 million children and adolescents less than 16 years of age. In this population, there are 200 aVected people, 196 of whom are alive at the time of evaluation. An estimated 2% of all those with LQTS die without having a previously recognised episode of arrhythmia. 6 7 Among families with KVLQT1 mutations, 63% of aVected persons and 7% of unaVected persons have a history of fainting. 6 The rate of fainting is less in families with HERG (46%) and SCN5A (18%) mutations, but these mutations are less common. 5 7 The overall rate for fainting in the population with LQTS is estimated to be 50%; the corresponding rate for the non-LQTS population is 7%. According to these estimates, 98 aVected children and 70 000 unaVected children have such a history.
In this analysis, all children who faint are assumed to be available for assessment and ECG. In the future, it might be possible to perform DNA analysis in children whose QTc measurements are in the range of 0.44 to 0.48 seconds, rather than measure the QTc in both parents. Figure 3 shows how this approach might perform in comparison with the parental ECG approach. DNA analysis can identify 50% of aVected people, and the false positive rate is assumed to be 0.01%. 5 This translates into 25 additional cases being identified, along with one or two false positives (the corresponding numbers for the parental ECG approach are 21 additional cases and 25 false positives).
COSTS OF ECG EVALUATION AFTER A FAINT
The rough cost of ECG is $100 in the oYce setting. In a hypothetical group of 1 million children, the total test cost for an ECG after a faint would be $9 511 600 ($100×70 098 children evaluated+$100×25 018 parents evaluated). The test cost, therefore, would be $150 978/case detected and $452 933/death avoided. This assumes that one third of the children with LQTS would die if not treated and that treatment is 100% eVective.
Discussion
In a separate analysis, 5 we have evaluated the performance of the rate corrected QT interval in population screening, and conclude that this approach is not feasible. The present study examines an alternative strategy to systematically detect children with LQTS in the setting of their initial evaluation for fainting. We have chosen children for our model because risk of sudden death is greatest before 16 years of age. 7 The event that most commonly precedes sudden death is a fainting episode. Fainting suggests that the child with LQTS has escaped from an episode of ventricular tachycardia and, possibly, ventricular fibrillation. 8 Once LQTS is recognised, long term treatment with -blockers is eVective in preventing most of these cardiac events. [2] [3] [4] Previous recommendations for detecting LQTS have relied on family history and the corrected QT interval 9 or a scoring system. The scoring system suggested by Schwartz et al 10 uses historical information and other ECG variables, as well as the corrected QT interval, to assign a probability of LQTS in a person. The false positive rates for many of the variables in this scoring system have not been ascertained. One exception, however, is a history of fainting, which has been quantified in genotyped families. Vincent et al 6 noted that 63% of aVected and 7% of unaVected family members reported fainting in families with linkage to the KVLQT1 gene. This information was obtained in an unbiased manner, before knowledge of genetic status. Zareba et al 7 noted a similar rate for those with KVLQT1 mutations (62%) but a lower rate for the less frequent mutations in the HERG and SCN5A genes (46 and 18%, respectively).
The history of fainting yields a seven-fold enrichment in the prior odds of LQTS. This allows a lower QTc cut oV point to be used than for population screening to detect LQTS. 5 In addition, it can be performed at one fourth the test cost/death avoided that has been estimated using population screening ($452 933 v $2 222 000). The strategy of evaluating children for LQTS after fainting also has the advantage of capturing families during a medical encounter, when they are likely to perceive detection and treatment of LQTS as important.
According to the present strategy, all of the children with QTc measurements of 0.49 seconds or greater are candidates for treatment, even though 17 children without LQTS will need to be treated for every 10 children with LQTS. A health care provider might be tempted to make use of DNA analysis to avoid the need to treat the unaVected children (it is currently recommended that treatment be continued into the 5th decade). This would be a mistake, because five of the 10 children with LQTS would also be found not to have a known mutation. DNA analysis in this select group of high risk children could be useful, however, in identifying secondary cases within families, when a mutation is found.
A second component of the present strategy calls for further study in a subgroup of children with a history of fainting whose QTc measurements are between 0.44 and 0.48 seconds. The risk for LQTS in these children is considerably higher (1:250) than in the general population (1:5000), but not high enough to warrant treatment. We have modelled the performance of a first step in assessing these children: QTc measurements in both parents. Although cumbersome and relatively labour intensive, it does oVer an opportunity to identify more children with LQTS, along with only a few false positives. The same guidelines for treatment hold for this group as for the children with QTc measurements at or above 0.49 seconds. For those children whose parents have a QTc less than 0.49 seconds (28 with LQTS and 12 435 without LQTS in fig 2) further testing might be considered. This could include exercise testing and holter monitoring in the children and the parents-especially if there was a history of multiple fainting episodes or fainting with exercise or startle. However, modelling the performance of these procedures in aVected and unaVected children would need to done before applying these tests routinely given the many children without LQTS who faint, usually for benign reasons.
In the future, DNA analysis for LQTS mutations may become available for routine clinical use. If that happens, it would be more practical to perform DNA analysis on the children with QTc measurements in the intermediate range than to do QTc measurements in both parents. The number of cases detected by parental ECG versus the child's DNA is similar, but DNA testing would reduce the false positives considerably.
Finally, what problems are associated with the proposed strategy? Our estimates of fainting rates in children are based on information obtained from families with LQTS. Published estimates of fainting rates vary widely. If the information is obtained from questionnaires, 12% to 48% of various groups report at least a single episode of fainting. [11] [12] [13] In addition, our model assumes that parents will always seek medical attention for the child who faints. The best population based estimate of the prevalence of children and adolescents seeking medical attention for fainting comes from the Mayo Clinic. 14 In that survey, about 0.1% of clinic visits for children and adolescents were because of fainting. This suggests that many children who experience a fainting episode may not seek medical attention. These uncertainties might be addressed by pilot studies aimed at documenting the prevalence of fainting in the general population and, also, the proportion who seek medical attention. Sudden death due to LQTS will continue to occur, even if the proposed strategy were to be optimally implemented. Two per cent of persons die during their initial arrhythmia, and only about of one third of surviving children would be detected, using the proposed approach. The current strategy, however, provides the best available guidance for detecting LQTS systematically and should be incorporated into the primary care evaluation of fainting.
